Synergy between health technology assessments and clinical guidelines for multiple sclerosis
Abstract Decision‐making for reimbursement and clinical guidelines (CGs) serves different purposes although the decision‐criteria and required evidence largely overlap. This study aimed to assess similarities and discrepancies between health technology assessment (HTA) reports as compared to CGs for...
Saved in:
Main Authors: | Milou A. Hogervorst (Author), Rick A. Vreman (Author), Anna Zawada (Author), Magdalena Zielińska (Author), Dalia M. Dawoud (Author), Brigit A. deJong (Author), Aukje K. Mantel‐Teeuwisse (Author), Wim G. Goettsch (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real World Data in Health Technology Assessment of Complex Health Technologies
by: Milou A. Hogervorst, et al.
Published: (2022) -
The Role of Regulator-Imposed Post-Approval Studies in Health Technology Assessments for Conditionally Approved Drugs
by: Rick A. Vreman, et al.
Published: (2022) -
Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies
by: Lourens T. Bloem, et al.
Published: (2021) -
'So Let's Go On Like This?'-Shared Decision‐Making and the Use of Outcome Information in Routine Care Management for People With Multiple Sclerosis
by: Olga C. Damman, et al.
Published: (2024) -
Bridging the gap: Can International Consortium of Health Outcomes Measurement standard sets align outcomes accepted for regulatory and health technology assessment decision‐making of oncology medicines
by: Rachel R. J. Kalf, et al.
Published: (2021)